Viamet to Participate in Antifungal Panel Discussion at the 2017 BIO International Convention

Viamet Pharmaceuticals, Inc. today announced that Robert Schotzinger, M.D., Ph.D., President and CEO of Viamet, will be participating in a panel discussion on emerging issues and unmet needs in antifungal development at the 2017 BIO International Convention, taking place on June 19-22 at the San Diego Convention Center in San Diego, CA. The interactive panel will focus on the growing global public health epidemic caused by pathogenic fungi and highlight the urgent need and opportunities for new antifungal therapies. The session titled, “Antifungus Among Us: Recognizing Vulnerability and Opportunity with the Next-Generation of Antifungals,” will take place on June 20 at 4:15pm PT, and will include experts and representatives from all aspects of these issues including media, regulatory bodies and biotechnology companies.